基于药物转录学的发现和凝介导的药物组合的输送,用于潜在的癌症免疫疗法
Rong Liu1, Hui-Han Yu2, Wei-Rong Li3
1School of Medicine, South China University of Technology, Guangzhou 510006, China; Guangdong Institute for Drug Control, NMPA Key Laboratory of Quality Control and Evaluation of Pharmaceutical Excipient, Guangzhou 510663, China.
Science bulletin
|January 24, 2026
概括
这项研究引入了一个新的药物选平台,以确定有效的癌症治疗组合. 一种水凝同时提供雷斯基莫德和密托克桑特龙,成功抑制了瘤并增强了免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物输送系统 药物输送系统
背景情况:
- 组合疗法对于固体瘤治疗至关重要,但在药物选择和输送方面面临挑战.
- 为增强癌症免疫疗法开发合理的药物组合仍然是一个重大障碍.
研究的目的:
- 开发一个基于omics的平台,用于预测癌症免疫治疗的有效药物组合.
- 设计一种局部传递系统,用于向巨介导免疫反应的组合疗法.
主要方法:
- 开发了用于高通量药物查的药物转录组特征丰富分析 (PSEA).
- 确定了米托克桑 (MIT) 作为使用PSEA的瑞西基莫德 (R848) 的组合合作伙伴.
- 设计了一种共同装载的水凝 (MIT/R848@Gel) 进行局部分泌,并在多种瘤模型中进行了测试.
主要成果:
- 在临床前模型中,MIT/R848@Gel抑制了初级瘤,复发和转移.
- 组合疗法诱导了持久的全身抗瘤免疫反应,导致长期缓解.
- MIT/R848@Gel将免疫抑制性巨细胞重新编程为抗瘤表型,并激活细胞毒性T细胞.
结论:
- 建立了一个新的框架,将omics驱动的药物发现与局部组合疗法相结合.
- 通过调节瘤微环境,证明了MIT/R848@Gel在增强癌症免疫疗法的潜力.
- 在癌症治疗中,PSEA平台为合理的药物组合发现提供了一个有前途的方法.
相关概念视频
Drug Discovery: Overview
11.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.3K
Drug Delivery: Overview
761
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
761
Drug Delivery: Enteral Route
1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K
Drug Delivery: Parenteral Route
1.6K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.6K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


